Target intelligence / Profile preview

Mitochondrially encoded cytochrome c oxidase II pseudogene 30 (MTCO2P30)

Target
MTCO2P30
Molecular classification
Other (Pseudogene)
01

Overview

Mitochondrially encoded cytochrome c oxidase II pseudogene 30 (MTCO2P30) is classified as a pseudogene in the human genome. Located on chromosome 5, MTCO2P30 shares homology with the functional MT-CO2 gene but contains mutations and/or truncations that prevent it from producing a functional protein product[1][5]. Pseudogenes like MTCO2P30 are considered inactive remnants of once-functional genes; while some pseudogenes can affect gene expression via non-coding RNA mechanisms or through competing endogenous RNA effects, there is no evidence that MTCO2P30 itself has such function[9]. It is not involved in mitochondrial electron transport and has no known role in disease, biomarker use, or drug interaction. It should not be considered a receptor, enzyme, transporter, or any canonical therapeutic target. If you require structured information on the functional MT-CO2 gene, refer instead to Mitochondrially encoded cytochrome c oxidase II (MT-CO2), which is a bona fide enzyme and therapeutic biomarker involved in mitochondrial respiratory complex IV[3][7].

Other names
MT-CO2 pseudogene 30MTCO2P30
02

Biological functions

None established for the pseudogene itself; pseudogenes typically lack direct biological function but can sometimes act through RNA-mediated regulation in rare cases
03

Disease associations

None established for MTCO2P30; MT-CO2 gene mutations (not pseudogenes) are linked to mitochondrial disorders

Beyond the preview

Go deeper on Mitochondrially encoded cytochrome c oxidase II pseudogene 30 (MTCO2P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase II pseudogene 30 (MTCO2P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call